Position in DMAC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$329,991
-$383,700 QoQ
Shares Held
46,874
-55.5% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 87 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in DMAC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. DMAC ranks #295 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in DMAC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $329,991 | 46,874 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $713,691 | 105,420 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,358,973 | 547,610 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,981,747 | 579,585 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $937,855 | 240,476 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $392,578 | 103,583 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $474,739 | 87,429 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $460,966 | 110,016 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $254,290 | 86,200 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $253,656 | 91,573 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $343,625 | 120,995 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $242,004 | 93,800 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $246,672 | 57,100 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $87,497 | 57,188 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $87,222 | 55,201 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $65,728 | 53,007 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $96,556 | 47,800 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $83,557 | 33,423 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $89,147 | 23,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $45,714 | 11,400 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $105,139 | 23,627 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $177,738 | 19,425 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $209,492 | 20,660 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $38,584 | 9,100 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $40,194 | 5,800 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||